Dr. Yafei Wang, Hematologist - Beijing, China

Dr. Yafei Wang is a highly distinguished, board-certified Hematologist and leading medical researcher specializing in advanced blood cancer treatments and cellular therapies. With an extensive clinical background, Dr. Wang currently serves as the Director of the Hematology Department at the prestigious Tianjin Medical University Cancer Hospital and holds the critical role of Leader of the Department of Blood Transplantation at the Airport Hospital, Tianjin Cancer Hospital. Furthermore, he is a primary specialist associated with the Beijing Bioocus International Medical Center, where he provides world-class consultations and treatment protocols for international and domestic patients facing complex hematological conditions.

Holding a Doctor of Medicine (M.D.) and serving as a Master’s thesis supervisor, Dr. Wang bridges the gap between academic research and cutting-edge clinical practice. He is a prominent "botanic physician" and heavily engaged in both the basic and clinical research of multiple myeloma, lymphoma, and leukemia. Dr. Wang has presided over numerous high-level national and regional medical projects, including initiatives funded by the National Natural Science Foundation, the Tianjin Natural Science Foundation, and the Ministry of Education New Teacher Fund. His profound leadership in Chinese hematology is reflected in his standing roles across more than ten national oncology and hematology committees.

Medical Expertise & Specializations

Dr. Yafei Wang’s medical expertise lies at the complex intersection of clinical hematology, oncology, and advanced cell and gene therapies. Throughout his prestigious career, he has dedicated his practice to combating some of the most aggressive forms of blood cancer. As a leader in blood transplantation, Dr. Wang utilizes cutting-edge therapeutic modalities to treat patients who have relapsed or are refractory to standard chemotherapy and radiation. His dual roles as a clinician and a lead researcher ensure that his patients have access to the most innovative, evidence-based treatments available globally.

Dr. Wang is recognized nationally and internationally for his deep involvement in basic and clinical research concerning multiple myeloma, lymphoma, and leukemia. By leading research projects for the Ministry of Education and the National Natural Science Foundation, he continually contributes to the evolution of targeted therapies, immunotherapy, and hematopoietic stem cell transplantation protocols. His approach is highly personalized, focusing on the genetic and molecular profile of each patient's disease to maximize treatment efficacy while minimizing systemic toxicity.

Conditions Treated

Drawing upon decades of advanced medical study and clinical practice, Dr. Wang expertly diagnoses, stages, and treats a comprehensive spectrum of hematological and oncological conditions. His primary clinical focus includes:

• Multiple Myeloma (MM): Comprehensive management of plasma cell neoplasms, including relapsed and refractory cases requiring advanced cellular interventions and stem cell therapies.
• Lymphoma: Treatment of diverse lymphatic system cancers, with specialized expertise in Non-Hodgkin Lymphoma (NHL) variants.
• Leukemia: Advanced protocols for acute and chronic blood and bone marrow cancers, including Acute Lymphoblastic Leukemia (B-ALL and T-ALL) and Acute Myeloid Leukemia (AML).
• Systemic Lupus Erythematosus (SLE): Utilizing groundbreaking therapies, such as CAR-T, to treat severe, treatment-resistant autoimmune disorders.
• Solid Tumors: Consulting on advanced cell therapy applications for solid malignancies, including Neuroblastoma, Glioblastoma, Gastric Cancer, and Hepatocellular Carcinoma.
• Genetic Blood Disorders: Interventions for complex hemoglobinopathies, including Sickle Cell Disease and Beta-Thalassemia.

Procedures Performed

As the Leader of the Department of Blood Transplantation, Dr. Wang is at the forefront of administering life-saving cellular and immunological procedures. His procedural expertise includes:

• Hematopoietic Stem Cell Transplantation (Blood Transplantation): Autologous and allogeneic stem cell transplants for the total replacement of diseased bone marrow, crucial for leukemia and myeloma patients.
• CAR-T Cell Therapy: Administering Chimeric Antigen Receptor T-cell therapy, including fully human BCMA CAR-T (FUCASO), to specifically target and destroy cancer cells in B-ALL, MM, and NHL patients.
• TILs Therapy (Tumor-Infiltrating Lymphocytes): Advanced immunotherapies targeting solid tumors such as melanoma.
• NK Cell Therapy: Natural Killer cell therapies designed to enhance the body's innate immune response against malignant tumors.
• Oncolytic Virus Therapy: Utilizing genetically modified viruses to selectively infect and eradicate cancer cells.
• Gene Therapy Administration: Delivering corrective genetic material for conditions like Thalassemia and Spinal Muscular Atrophy (Nusinersen Sodium Injection).

Education, Training & Professional Leadership

Dr. Yafei Wang’s academic and professional credentials position him as an elite figure in Chinese hematology. He earned his Doctor of Medicine (M.D.) with a rigorous focus on oncology and blood diseases. Beyond his clinical practice, he shapes the future of medical science as a Master's thesis supervisor, mentoring the next generation of hematologists and oncologists. His thought leadership is universally recognized, as evidenced by his extensive involvement in the nation's top medical boards and societies.

Professional Memberships and Social Positions:

• Member of the Hematology Professional Committee, Chinese Anti-Cancer Association
• Member of the Myeloma Professional Committee of the Chinese Society of Clinical Oncology
• Deputy Director of the Plasma Cell Society of the China Health Promotion Association
• Member of the Hematology Rehabilitation Committee of the Chinese Society of Rehabilitation Medicine
• Member of the Hematology Branch, Chinese National Medical Association
• Member of the Hematology Professional Committee of the Chinese Society of Integrated Traditional and Western Medicine
• Deputy Director of the Hematology and Oncology Professional Committee of the Tianjin Anti-Cancer Association
• Deputy Director of the Bone and Soft Tissue Professional Committee of the Tianjin Anti-Cancer Association
• Standing Director of the Tianjin Health Education Association
• Standing Director of the Tianjin Medical and Health Society

Frequently Asked Questions (FAQ)

To assist patients in understanding the scope of Dr. Wang's practice, we have compiled answers to the most common questions regarding his medical services and hematology expertise.

Ready to Explore Advanced Hematology Care with Dr. Yafei Wang?

Facing a complex blood cancer or autoimmune diagnosis requires the intervention of a world-renowned expert. PlacidWay partners with elite medical professionals and state-of-the-art facilities like the Beijing Bioocus International Medical Center to provide you with seamless access to Dr. Yafei Wang's innovative treatments and cellular therapies.

Contact PlacidWay today to schedule your initial medical evaluation with Dr. Yafei Wang. Our dedicated coordination team will help you submit your medical records, receive a personalized treatment protocol, and manage all logistics for your medical journey to China. Let us handle the details so you can focus entirely on your health and recovery.